Treatment of Viral Conjunctivitis

Diagnosis and Clinical Features

Viral conjunctivitis is primarily self-limited and requires supportive care rather than antimicrobial treatment, as recommended by the American Academy of Ophthalmology 1, 2

The American Academy of Ophthalmology recommends no antimicrobial treatment for uncomplicated viral conjunctivitis, as it is self-limited 1, 2
Supportive measures, including artificial tears, cold compresses, and topical antihistamines, can provide symptomatic relief, as suggested by the American Academy of Ophthalmology 1, 2
Topical corticosteroids may be helpful in severe cases with marked chemosis, epithelial sloughing, or membranous conjunctivitis, but should be used with caution and close follow-up, as recommended by the American Academy of Ophthalmology 1, 3
Antibiotics should be avoided as they provide no benefit for viral infections and may cause toxicity, according to the American Academy of Ophthalmology 1, 2

Patient education about the highly contagious nature of viral conjunctivitis is critical, and patients should be advised to minimize contact with others, practice strict hand hygiene, and avoid sharing personal items, as recommended by the American Academy of Ophthalmology 1
Healthcare setting precautions, including proper disinfection of equipment and consideration of abbreviated examination in dedicated exam rooms, can help prevent the spread of infection, as suggested by the American Academy of Ophthalmology 1, 4, 5

Patients with severe disease should be re-evaluated within 1 week, and those on topical corticosteroids require regular monitoring of IOP and pupillary dilation, as recommended by the American Academy of Ophthalmology 3
Patients not on corticosteroids should return if symptoms persist beyond 2-3 weeks, and monitoring for development of subepithelial infiltrates is necessary, according to the American Academy of Ophthalmology 3

Prompt referral to an ophthalmologist is indicated for patients with visual loss, moderate or severe pain, corneal involvement, lack of response to therapy, history of HSV eye disease, or immunocompromised status, as recommended by the American Academy of Ophthalmology 6